Antibiotic prophylaxis for patients undergoing breast surgery
Identifieur interne : 005534 ( Istex/Corpus ); précédent : 005533; suivant : 005535Antibiotic prophylaxis for patients undergoing breast surgery
Auteurs : J. C Hall ; J. L HallSource :
- Journal of Hospital Infection [ 0195-6701 ] ; 2000.
English descriptors
- KwdEn :
Abstract
Some groups of patients undergoing clean surgery benefit from the provision of antibiotic prophylaxis against wound infection. Breast surgery may belong to this category because several substantial studies have reported that it is accompanied by an unacceptably high rate of wound infection. However, only two clinical trials have addressed this issue and both produced equivocal results. Resolution of this problem is important because, aside from the usual advantages obtained by preventing such complications, wound infection diminishes the proportion of patients with breast cancer who start adjuvant regimens within an optimum time after surgery.
Url:
DOI: 10.1053/jhin.2000.0834
Links to Exploration step
ISTEX:B5B2E37CC5C2602EC8A7A7C3743B7A50B12BF9AFLe document en format XML
<record><TEI wicri:istexFullTextTei="biblStruct"><teiHeader><fileDesc><titleStmt><title xml:lang="en">Antibiotic prophylaxis for patients undergoing breast surgery</title><author><name sortKey="Hall, J C" sort="Hall, J C" uniqKey="Hall J" first="J. C" last="Hall">J. C Hall</name><affiliation><mods:affiliation>University Department of Surgery, Royal Perth Hospital, Western Australia, Australia</mods:affiliation></affiliation></author><author><name sortKey="Hall, J L" sort="Hall, J L" uniqKey="Hall J" first="J. L" last="Hall">J. L Hall</name><affiliation><mods:affiliation>University Department of Surgery, Royal Perth Hospital, Western Australia, Australia</mods:affiliation></affiliation></author></titleStmt><publicationStmt><idno type="wicri:source">ISTEX</idno><idno type="RBID">ISTEX:B5B2E37CC5C2602EC8A7A7C3743B7A50B12BF9AF</idno><date when="2000" year="2000">2000</date><idno type="doi">10.1053/jhin.2000.0834</idno><idno type="url">https://api.istex.fr/document/B5B2E37CC5C2602EC8A7A7C3743B7A50B12BF9AF/fulltext/pdf</idno><idno type="wicri:Area/Istex/Corpus">005534</idno><idno type="wicri:explorRef" wicri:stream="Istex" wicri:step="Corpus" wicri:corpus="ISTEX">005534</idno></publicationStmt><sourceDesc><biblStruct><analytic><title level="a" type="main" xml:lang="en">Antibiotic prophylaxis for patients undergoing breast surgery</title><author><name sortKey="Hall, J C" sort="Hall, J C" uniqKey="Hall J" first="J. C" last="Hall">J. C Hall</name><affiliation><mods:affiliation>University Department of Surgery, Royal Perth Hospital, Western Australia, Australia</mods:affiliation></affiliation></author><author><name sortKey="Hall, J L" sort="Hall, J L" uniqKey="Hall J" first="J. L" last="Hall">J. L Hall</name><affiliation><mods:affiliation>University Department of Surgery, Royal Perth Hospital, Western Australia, Australia</mods:affiliation></affiliation></author></analytic><monogr></monogr><series><title level="j">Journal of Hospital Infection</title><title level="j" type="abbrev">YJHIN</title><idno type="ISSN">0195-6701</idno><imprint><publisher>ELSEVIER</publisher><date type="published" when="2000">2000</date><biblScope unit="volume">46</biblScope><biblScope unit="issue">3</biblScope><biblScope unit="page" from="165">165</biblScope><biblScope unit="page" to="170">170</biblScope></imprint><idno type="ISSN">0195-6701</idno></series></biblStruct></sourceDesc><seriesStmt><idno type="ISSN">0195-6701</idno></seriesStmt></fileDesc><profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Breast disease</term><term>antibiotics</term><term>breast cancer</term><term>prophylaxis</term><term>surgery</term><term>wound infection</term></keywords></textClass><langUsage><language ident="en">en</language></langUsage></profileDesc></teiHeader><front><div type="abstract" xml:lang="en">Some groups of patients undergoing clean surgery benefit from the provision of antibiotic prophylaxis against wound infection. Breast surgery may belong to this category because several substantial studies have reported that it is accompanied by an unacceptably high rate of wound infection. However, only two clinical trials have addressed this issue and both produced equivocal results. Resolution of this problem is important because, aside from the usual advantages obtained by preventing such complications, wound infection diminishes the proportion of patients with breast cancer who start adjuvant regimens within an optimum time after surgery.</div></front></TEI><istex><corpusName>elsevier</corpusName><keywords><teeft><json:string>wound infection</json:string><json:string>breast surgery</json:string><json:string>mastectomy</json:string><json:string>prophylaxis</json:string><json:string>prophylactic</json:string><json:string>breast cancer</json:string><json:string>antibiotic</json:string><json:string>prophylactic antibiotics</json:string><json:string>surg</json:string><json:string>preoperative</json:string><json:string>chemotherapy</json:string><json:string>clinical trial</json:string><json:string>wound infections</json:string><json:string>morbidity</json:string><json:string>antibiotic prophylaxis</json:string><json:string>adjuvant</json:string><json:string>clinical trials</json:string><json:string>open biopsy</json:string><json:string>preoperative chemotherapy</json:string><json:string>surgery</json:string><json:string>infection</json:string><json:string>breast procedures</json:string><json:string>absolute reduction</json:string><json:string>wound infection rate</json:string><json:string>early discharge</json:string><json:string>biopsy</json:string><json:string>breast reconstruction</json:string><json:string>suction drainage</json:string><json:string>wound infection rates</json:string><json:string>perioperative antibiotic prophylaxis</json:string><json:string>clean surgery</json:string><json:string>clean wounds</json:string><json:string>wound haematoma</json:string><json:string>significant reduction</json:string><json:string>fine needle aspiration</json:string><json:string>radical mastectomy</json:string><json:string>breast</json:string></teeft></keywords><author><json:item><name>J.C Hall</name><affiliations><json:string>University Department of Surgery, Royal Perth Hospital, Western Australia, Australia</json:string></affiliations></json:item><json:item><name>J.L Hall</name><affiliations><json:string>University Department of Surgery, Royal Perth Hospital, Western Australia, Australia</json:string></affiliations></json:item></author><subject><json:item><lang><json:string>eng</json:string></lang><value>Breast disease</value></json:item><json:item><lang><json:string>eng</json:string></lang><value>breast cancer</value></json:item><json:item><lang><json:string>eng</json:string></lang><value>surgery</value></json:item><json:item><lang><json:string>eng</json:string></lang><value>antibiotics</value></json:item><json:item><lang><json:string>eng</json:string></lang><value>prophylaxis</value></json:item><json:item><lang><json:string>eng</json:string></lang><value>wound infection</value></json:item></subject><language><json:string>eng</json:string></language><originalGenre><json:string>Review article</json:string></originalGenre><abstract>Some groups of patients undergoing clean surgery benefit from the provision of antibiotic prophylaxis against wound infection. Breast surgery may belong to this category because several substantial studies have reported that it is accompanied by an unacceptably high rate of wound infection. However, only two clinical trials have addressed this issue and both produced equivocal results. Resolution of this problem is important because, aside from the usual advantages obtained by preventing such complications, wound infection diminishes the proportion of patients with breast cancer who start adjuvant regimens within an optimum time after surgery.</abstract><qualityIndicators><score>4.252</score><pdfVersion>1.3</pdfVersion><pdfPageSize>595 x 793 pts</pdfPageSize><refBibsNative>true</refBibsNative><keywordCount>6</keywordCount><abstractCharCount>651</abstractCharCount><pdfWordCount>3136</pdfWordCount><pdfCharCount>20414</pdfCharCount><pdfPageCount>6</pdfPageCount><abstractWordCount>93</abstractWordCount></qualityIndicators><title>Antibiotic prophylaxis for patients undergoing breast surgery</title><pii><json:string>S0195-6701(00)90834-X</json:string></pii><genre><json:string>review-article</json:string></genre><host><title>Journal of Hospital Infection</title><language><json:string>unknown</json:string></language><publicationDate>2000</publicationDate><issn><json:string>0195-6701</json:string></issn><pii><json:string>S0195-6701(00)X0015-1</json:string></pii><volume>46</volume><issue>3</issue><pages><first>165</first><last>170</last></pages><genre><json:string>journal</json:string></genre></host><categories><wos><json:string>science</json:string><json:string>infectious diseases</json:string></wos><scienceMetrix><json:string>health sciences</json:string><json:string>public health & health services</json:string><json:string>epidemiology</json:string></scienceMetrix><inist><json:string>sciences appliquees, technologies et medecines</json:string><json:string>sciences biologiques et medicales</json:string><json:string>sciences medicales</json:string></inist></categories><publicationDate>2000</publicationDate><copyrightDate>2000</copyrightDate><doi><json:string>10.1053/jhin.2000.0834</json:string></doi><id>B5B2E37CC5C2602EC8A7A7C3743B7A50B12BF9AF</id><score>1</score><fulltext><json:item><extension>pdf</extension><original>true</original><mimetype>application/pdf</mimetype><uri>https://api.istex.fr/document/B5B2E37CC5C2602EC8A7A7C3743B7A50B12BF9AF/fulltext/pdf</uri></json:item><json:item><extension>zip</extension><original>false</original><mimetype>application/zip</mimetype><uri>https://api.istex.fr/document/B5B2E37CC5C2602EC8A7A7C3743B7A50B12BF9AF/fulltext/zip</uri></json:item><istex:fulltextTEI uri="https://api.istex.fr/document/B5B2E37CC5C2602EC8A7A7C3743B7A50B12BF9AF/fulltext/tei"><teiHeader><fileDesc><titleStmt><title level="a" type="main" xml:lang="en">Antibiotic prophylaxis for patients undergoing breast surgery</title></titleStmt><publicationStmt><authority>ISTEX</authority><publisher>ELSEVIER</publisher><availability><p>©2000 The Hospital Infection Society</p></availability><date>2000</date></publicationStmt><notesStmt><note type="content">Section title: Reveiew</note></notesStmt><sourceDesc><biblStruct type="inbook"><analytic><title level="a" type="main" xml:lang="en">Antibiotic prophylaxis for patients undergoing breast surgery</title><author xml:id="author-0000"><persName><forename type="first">J.C</forename><surname>Hall</surname></persName><affiliation>Author for correspondence: Prof. J. C. Hall, University Department of Surgery, Royal Perth Hospital, Wellington Street, Perth, WA 6000, Australia. Fax: 61-8-9224-0204; E-mail:jchall@cyllene.uwa.edu.au</affiliation><affiliation>University Department of Surgery, Royal Perth Hospital, Western Australia, Australia</affiliation></author><author xml:id="author-0001"><persName><forename type="first">J.L</forename><surname>Hall</surname></persName><affiliation>University Department of Surgery, Royal Perth Hospital, Western Australia, Australia</affiliation></author><idno type="istex">B5B2E37CC5C2602EC8A7A7C3743B7A50B12BF9AF</idno><idno type="DOI">10.1053/jhin.2000.0834</idno><idno type="PII">S0195-6701(00)90834-X</idno></analytic><monogr><title level="j">Journal of Hospital Infection</title><title level="j" type="abbrev">YJHIN</title><idno type="pISSN">0195-6701</idno><idno type="PII">S0195-6701(00)X0015-1</idno><imprint><publisher>ELSEVIER</publisher><date type="published" when="2000"></date><biblScope unit="volume">46</biblScope><biblScope unit="issue">3</biblScope><biblScope unit="page" from="165">165</biblScope><biblScope unit="page" to="170">170</biblScope></imprint></monogr></biblStruct></sourceDesc></fileDesc><profileDesc><creation><date>2000</date></creation><langUsage><language ident="en">en</language></langUsage><abstract xml:lang="en"><p>Some groups of patients undergoing clean surgery benefit from the provision of antibiotic prophylaxis against wound infection. Breast surgery may belong to this category because several substantial studies have reported that it is accompanied by an unacceptably high rate of wound infection. However, only two clinical trials have addressed this issue and both produced equivocal results. Resolution of this problem is important because, aside from the usual advantages obtained by preventing such complications, wound infection diminishes the proportion of patients with breast cancer who start adjuvant regimens within an optimum time after surgery.</p></abstract><textClass xml:lang="en"><keywords scheme="keyword"><list><head>Keywords</head><item><term>Breast disease</term></item><item><term>breast cancer</term></item><item><term>surgery</term></item><item><term>antibiotics</term></item><item><term>prophylaxis</term></item><item><term>wound infection</term></item></list></keywords></textClass></profileDesc><revisionDesc><change when="2000">Published</change></revisionDesc></teiHeader></istex:fulltextTEI><json:item><extension>txt</extension><original>false</original><mimetype>text/plain</mimetype><uri>https://api.istex.fr/document/B5B2E37CC5C2602EC8A7A7C3743B7A50B12BF9AF/fulltext/txt</uri></json:item></fulltext><metadata><istex:metadataXml wicri:clean="Elsevier, elements deleted: tail"><istex:xmlDeclaration>version="1.0" encoding="utf-8"</istex:xmlDeclaration><istex:docType PUBLIC="-//ES//DTD journal article DTD version 4.5.2//EN//XML" URI="art452.dtd" name="istex:docType"></istex:docType><istex:document><converted-article version="4.5.2" docsubtype="rev" xml:lang="en"><item-info><jid>YJHIN</jid><aid>90834</aid><ce:pii>S0195-6701(00)90834-X</ce:pii><ce:doi>10.1053/jhin.2000.0834</ce:doi><ce:copyright type="society" year="2000">The Hospital Infection Society</ce:copyright></item-info><head><ce:dochead><ce:textfn>Reveiew</ce:textfn></ce:dochead><ce:title>Antibiotic prophylaxis for patients undergoing breast surgery</ce:title><ce:author-group><ce:author><ce:given-name>J.C</ce:given-name><ce:surname>Hall</ce:surname><ce:cross-ref refid="FN1"><ce:sup>f1</ce:sup><ce:footnote id="FN1"><ce:label>f1</ce:label><ce:note-para>Author for correspondence: Prof. J. C. Hall, University Department of Surgery, Royal Perth Hospital, Wellington Street, Perth, WA 6000, Australia. Fax: 61-8-9224-0204; E-mail:jchall@cyllene.uwa.edu.au</ce:note-para></ce:footnote></ce:cross-ref></ce:author><ce:author><ce:given-name>J.L</ce:given-name><ce:surname>Hall</ce:surname></ce:author><ce:affiliation><ce:textfn>University Department of Surgery, Royal Perth Hospital, Western Australia, Australia</ce:textfn></ce:affiliation></ce:author-group><ce:date-received day="11" month="7" year="1999"></ce:date-received><ce:date-accepted day="23" month="8" year="1999"></ce:date-accepted><ce:abstract><ce:section-title>Abstract</ce:section-title><ce:abstract-sec><ce:simple-para>Some groups of patients undergoing clean surgery benefit from the provision of antibiotic prophylaxis against wound infection. Breast surgery may belong to this category because several substantial studies have reported that it is accompanied by an unacceptably high rate of wound infection. However, only two clinical trials have addressed this issue and both produced equivocal results. Resolution of this problem is important because, aside from the usual advantages obtained by preventing such complications, wound infection diminishes the proportion of patients with breast cancer who start adjuvant regimens within an optimum time after surgery.</ce:simple-para></ce:abstract-sec></ce:abstract><ce:keywords><ce:section-title>Keywords</ce:section-title><ce:keyword><ce:text>Breast disease</ce:text></ce:keyword><ce:keyword><ce:text>breast cancer</ce:text></ce:keyword><ce:keyword><ce:text>surgery</ce:text></ce:keyword><ce:keyword><ce:text>antibiotics</ce:text></ce:keyword><ce:keyword><ce:text>prophylaxis</ce:text></ce:keyword><ce:keyword><ce:text>wound infection</ce:text></ce:keyword></ce:keywords></head></converted-article></istex:document></istex:metadataXml><mods version="3.6"><titleInfo lang="en"><title>Antibiotic prophylaxis for patients undergoing breast surgery</title></titleInfo><titleInfo type="alternative" lang="en" contentType="CDATA"><title>Antibiotic prophylaxis for patients undergoing breast surgery</title></titleInfo><name type="personal"><namePart type="given">J.C</namePart><namePart type="family">Hall</namePart><affiliation>University Department of Surgery, Royal Perth Hospital, Western Australia, Australia</affiliation><description>Author for correspondence: Prof. J. C. Hall, University Department of Surgery, Royal Perth Hospital, Wellington Street, Perth, WA 6000, Australia. Fax: 61-8-9224-0204; E-mail:jchall@cyllene.uwa.edu.au</description><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">J.L</namePart><namePart type="family">Hall</namePart><affiliation>University Department of Surgery, Royal Perth Hospital, Western Australia, Australia</affiliation><role><roleTerm type="text">author</roleTerm></role></name><typeOfResource>text</typeOfResource><genre type="review-article" displayLabel="Review article"></genre><originInfo><publisher>ELSEVIER</publisher><dateIssued encoding="w3cdtf">2000</dateIssued><copyrightDate encoding="w3cdtf">2000</copyrightDate></originInfo><language><languageTerm type="code" authority="iso639-2b">eng</languageTerm><languageTerm type="code" authority="rfc3066">en</languageTerm></language><physicalDescription><internetMediaType>text/html</internetMediaType></physicalDescription><abstract lang="en">Some groups of patients undergoing clean surgery benefit from the provision of antibiotic prophylaxis against wound infection. Breast surgery may belong to this category because several substantial studies have reported that it is accompanied by an unacceptably high rate of wound infection. However, only two clinical trials have addressed this issue and both produced equivocal results. Resolution of this problem is important because, aside from the usual advantages obtained by preventing such complications, wound infection diminishes the proportion of patients with breast cancer who start adjuvant regimens within an optimum time after surgery.</abstract><note type="content">Section title: Reveiew</note><subject lang="en"><genre>Keywords</genre><topic>Breast disease</topic><topic>breast cancer</topic><topic>surgery</topic><topic>antibiotics</topic><topic>prophylaxis</topic><topic>wound infection</topic></subject><relatedItem type="host"><titleInfo><title>Journal of Hospital Infection</title></titleInfo><titleInfo type="abbreviated"><title>YJHIN</title></titleInfo><genre type="journal">journal</genre><originInfo><dateIssued encoding="w3cdtf">200011</dateIssued></originInfo><identifier type="ISSN">0195-6701</identifier><identifier type="PII">S0195-6701(00)X0015-1</identifier><part><date>200011</date><detail type="volume"><number>46</number><caption>vol.</caption></detail><detail type="issue"><number>3</number><caption>no.</caption></detail><extent unit="issue pages"><start>163</start><end>240</end></extent><extent unit="pages"><start>165</start><end>170</end></extent></part></relatedItem><identifier type="istex">B5B2E37CC5C2602EC8A7A7C3743B7A50B12BF9AF</identifier><identifier type="DOI">10.1053/jhin.2000.0834</identifier><identifier type="PII">S0195-6701(00)90834-X</identifier><accessCondition type="use and reproduction" contentType="copyright">©2000 The Hospital Infection Society</accessCondition><recordInfo><recordContentSource>ELSEVIER</recordContentSource><recordOrigin>The Hospital Infection Society, ©2000</recordOrigin></recordInfo></mods></metadata><serie></serie></istex></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/LymphedemaV1/Data/Istex/Corpus
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 005534 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Istex/Corpus/biblio.hfd -nk 005534 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Wicri/Sante
|area= LymphedemaV1
|flux= Istex
|étape= Corpus
|type= RBID
|clé= ISTEX:B5B2E37CC5C2602EC8A7A7C3743B7A50B12BF9AF
|texte= Antibiotic prophylaxis for patients undergoing breast surgery
}}
| This area was generated with Dilib version V0.6.31. |  |